Enterprise League logo

Biotechnology Companies in United Kingdom (UK)

Biotechnology companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biotechnology sector based on self-reported profile data. The directory currently holds 191 companies in this sector. The largest share of listings is based in London. Related sectors on Enterprise League include Medical Equipment and Services, Life Science, Genetics, Pharmaceutical, Biopharma, Clinical Trials, Nanotechnology.
191 companies
London top city

Biotechnology
List of Biotechnology companies in United Kingdom (UK)

191 companies

Sort by

At Sano, our mission is to accelerate the future of personalised medicine. Our patient finding and engagement services enable researchers to deliver precision medicine clinical trials at increased speed and lower cost. Sano's end-to-end Platform integrates with your existing providers and partners, including sites, medical record retrieval services, sample collection and data analysis partners, and we apply our expert knowledge to identify new and highly efficient channels for finding and engaging the patients you need to support your project.
Biotechnology

2016

Science Creates is a deep tech ecosystem, supported and backed by successful entrepreneurs, that enables scientists and engineers to accelerate their ideas and build disruptive businesses. Our growing network of scientific startups are solving global problems with groundbreaking advancements in healthcare, the environment and quality of life. We have two research facilities in Bristol, a venture capital arm that offers investment into early-stage and scale-up deep tech companies, and an educational outreach charity. Our mission is to solve the world’s biggest challenges through deep tech.
Biotechnology

2020

Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
Biotechnology

2017

biomodal is an omics based life-sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus. Our duet multiomics solution enables more epigenetic information from a single, low input DNA library without complex, resource intensive bioinformatics or harsh chemical treatment. Our single-base-resolution, phased sequencing approach unlocks the combinatorial power of genetic and epigenetic information in one workflow, elucidating greater biological insight within the fields of cancer, neurodegenerative disease, and ageing.
Biotechnology

2012

Maintaining musculoskeletal health is the keystone of overall health as we get older. As we age our physical condition gradually deteriorates, leading to loss of strength, fitness and mobility. In most cases, this isn’t due to a simple decision to stop exercising. It is due to the breakdown of musculoskeletal function caused by disease. Musculoskeletal diseases such as osteoarthritis, tendinopathy and lower back pain are the primary causes of disability and early retirement in people over the age of 65. Currently, there are no approved disease-modifying drugs for these diseases, meaning that physical decline in old age is inevitable. At Causeway, we believe that physical decline in old age is not inevitable and in indeed may be reversible. To address this, we are developing a range of therapies that treat common MSK diseases that will allow us to remain fit and active into our nineties and beyond. Staying active as we get older also reduces the risk of developing osteoporosis, dementia, diabetes, obesity, cancer and cardiovascular disease. Finding a way to remain fit and active as we age isn’t just a personal imperative but also a global one. By 2050, one in four of us will be over 65 years old, the number of people age over 80 is projected to triple and retirement age to rise to 75-80 years old. As individuals and as a society, we need to find solutions to the problems of ageing. Our goal is to develop therapies that treat the most common MSK diseases, such as osteoarthritis, tendinopathy and lower back pain, re-defining what old age looks and feels like.
Pharmaceutical
Biopharma
Healthcare
Biotechnology
Therapeutics

2017

Founded in 2014, Edinburgh Molecular Imaging (EM Imaging) is a clinical phase biotechnology company focused on enabling image guided therapy. The company’s molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The focus of EM Imaging is the discovery and development of small molecules and peptides that, when conjugated with fluorescent dyes, target and specifically cancerous cells and other diseased tissue. This illumination will provide the clinician with a clearer view and decision-making tool to benefit the patient.
Biotechnology

2014

Hertility is a women’s health company built by women, for women. We’re shaping the future of reproductive healthcare by pioneering unique diagnostic testing that provides data-driven and advanced insights into reproductive health, fertility decline and the onset of menopause. We provide expert advice, education and access to care - all from the comfort of your home. Our research trials are a step towards fixing the currently flawed system. 31% of women will suffer from a reproductive health issue at some point and through our research, we aim to reduce the time to diagnosis through advanced at-home testing and specialist gynaecological care. We tailor pathways to the individual's reproductive goals, whether it be to explore their ovarian health and fertility options or overall hormonal health, such as confirming a PCOS diagnosis. Currently, we can diagnose 9 of the most common gynae pathologies which may lead to reduced fertility and signpost gynae cancers. Ultimately, our aim is to change attitudes around reproductive health, both for individuals and in the workplace, and to encourage women to be proactive by tracking their reproductive health. We’re calling this the Reproductive Revolution!
Medical
Healthcare
Biotechnology

2019

UTILITY therapeutics Ltd., a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today. Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended-spectrum beta-lactamases. Mecillinam, an intravenous (IV) formulation, is being developed as a first-line therapy for complicated UTI (cUTI) in the hospital setting.
Biotechnology

2017

Hidden within our planet's vast biodiversity are solutions to some of humanity's greatest challenges, with the potential to deliver sustainable food supplies, revolutionary manufacturing capabilities, and a new generation of medicines. At Basecamp Research, we are building BaseDiscovery, a platform technology that will use next-gen DNA analysis and environmental monitoring to connect the dots and improve our understanding of the natural world. Our team uses a unique and fully portable laboratory capable of rapidly analysing nature anywhere on Earth, discovering novel solutions to the world's most pressing challenges.
Biotechnology

2019

A proprietary light-driven, protein expression technology that uses chloroplasts to make extraordinarily high yields of proteins in plants. This game-changing manufacturing system is sustainable, free of animal pathogens and bacterial endotoxins, and highly scalable. Suitable for the recombinant protein contract manufacturing and development market. Bright Biotech is currently producing recombinant growth factors, which aid cell growth to promote regenerative medicine practices, and also industry processes such as clean meat production.
Biotechnology

2019

At Lifebit, we're pushing forward the frontiers of health and knowledge by democratising access to omics data. We enable all researchers, whether novice or advanced, to run complex analyses and generate meaningful insights fast. Lifebit CloudOS is the world’s first federated genomics platform for unified and secure research over distributed big data - wherever data resides. From top tier pharmaceutical organisations to global research institutes to genetics companies and more, Lifebit CloudOS leads the way with our best-in-class UX/UI, seamless integration to open-source tools, marketplace of proprietary ones, powerful cohort browser, and advanced AI functionality. At Lifebit, we are open source pioneers, innovators redefining our industry. Our driving mission - to revolutionise bioinformatics and biomedical data analysis forever. We are growing fast and looking for more superstars to join our team.
Biotechnology

2017

Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type. Mogrify is applying its proprietary and award-winning platforms to generate the functional cell types required to transform the lives of patients, by delivering a novel class of in vivo reprogramming therapies across ophthalmology, otology, metabolic and other areas of degenerative disease. Uniquely positioned to address a regenerative medicine market estimated to be worth $150 billion USD by 2028, Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications. Based in Cambridge, UK, the Company has raised over $40 million USD funding from Parkwalk, Ahren Innovation Capital, 24Haymarket, Trend Investment Group, Dr. Darrin M. Disley, OBE, Dr. Jonathan Milner and the University of Bristol Enterprise Fund III, as well as strategic investors; Astellas Venture Management.
Biotechnology

2019

Based outside Edinburgh, Roslin Technologies Limited is an ambitious food and agriculture technology company which creates disruptive biotechnologies to improve how proteins are made. Our core capabilities lie in developing and commercialising a suite of unique animal stem cells and resources for the nascent global cultivated meat industry. We were the first company to commercialise pluripotent stem cells which continually self-renew and are able differentiate into the fat and muscle tissue required in the cultivated meat industry. In addition, we are now focussing our R&D on addressing key challenges in the sector including production cost reduction and process scale-up. We have developed unique animal cells that work; our cells can self-renew forever and differentiate into any tissue, including muscle and fat. Our cells are favourable for cultivated meat production since they address consumer concerns, make meat more affordable, and simplify regulatory approvals. Besides cells for cultivated meat, we continue to look for other biotechnologies that help us make protein production more sustainable.
Biotechnology

2016

At Rhizocore, we develop technologies to grow symbiotic fungi that enhance the growth, resilience, and carbon sequestration potential of newly planted forests and woodlands. Whether it is for woodland restoration, commercial productivity, increasing tolerance to environmental stresses or capturing more carbon, our unique approach for growing locally-sourced mycorrhizal fungi ensures local adaptability to suit our customer's sites and needs. For more information email: info@rhizocore.com
Biotechnology

2021

For over twenty-five years we've been trading in used scientific equipment of almost every type and specification, giving us a broad base of knowledge which helps us assist our customers in sourcing the best value equipment on the market. Our ethos is rooted in our family approach—we are small, efficient and always ready to respond to the demands of our customers, some of whom we have been looking after for over twenty years. The team is headed by husband and wife Nick and Wendy Edmond and supported by their two sons Richard and Robert. Alongside them is a dedicated team dealing with sales, buying, administration and accounts. We deal with customers from universities, contract, private and public laboratories around the world. Our wealth of experience translates to excellent value for money for our customers, who are able to fully kit out laboratories or simply replace any old pieces of equipment at a fraction of the price of buying new. Don't hesitate to pick up the phone and let us know how we can help.
Biotechnology

1995

Synthace is a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. It allows biologists to design, plan, and automate experiments in a single place, then automatically gather structured experiment data and metadata in a unified no-code environment.
Biotechnology

2011

Pathology News is an exclusive community for pathologists and medical scientists interested in digital pathology, computational pathology, AI, tissue multiplexing, other trailblazing technologies and hot topics for pathology. Check out our scientific blog, industry news, careers, upcoming conferences and events, and use our exclusive Technology Buyer's Database to explore and search for scanners and other image capture devices, image management, image analysis and AI solutions, and contract service providers.
Biotechnology

2020

Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies.
Biotechnology

2015

Concept Life Sciences is a knowledge-based, science-led and customer-focused contract research and manufacturing organisation with world-leading expertise in the pharmaceutical, biotech and agrochemical industries. We are based across 5 sites in the UK delivering discovery research as well as GMP, GLP and GCP-regulated work. Whether it is delivering whole programs of research or bespoke studies we deliver a collaborative client-centred approach. Our services are built on scientist-to-scientist engagement, deep knowledge, flexibility and extensive in-house resources. Our services span and can scale to every stage from discovery to development: ✔️ Discovery chemistry ✔️ Immunology, immuno-oncology and neuroscience ✔️ Analytical services, including materials characterisation and physicochemical analysis ✔️ Process research and development ✔️ GMP manufacturing
Biotechnology

2014

🔵 What do we do? Multus is reinventing growth media for cell culture in cultivated meat and life science. From growth factors to serum-free supplements, we partner with companies looking for media breakthroughs to help accelerate their progress and de-risk their supply chain. 🔵 How do we do it better? We use a groundbreaking combination of data science, high-throughput automation and ISO-certified manufacturing to develop ingredients and formulations that reduce costs, eliminate animal-sourced components and enable scale-up. 🔵 Why do we do it? Our Mission is to make cultivated meat the sustainable and affordable choice, for everyone. To get there, every cultivated meat company needs to achieve the following growth media milestones: 1️⃣ Reduced input costs 2️⃣ Use of food-grade, animal-free ingredients that are sustainably sourced and aligned with regulation 3️⃣ Optimised formulations to improve bioprocess performance 4️⃣ Established scalable feedstocks where supply meets future production plans Companies that choose Multus see us as an indispensable partner in their journey to scaling cultivated meat production.
Biotechnology

2019

Eden Bio uses machine learning to improve protein yield, saving companies time and money, and helping them get their proteins to market faster.
Biotechnology

2021

Kyomei is a molecular farming and biotechnology start-up that focuses on the production of animal-identical proteins, pigments, ingredients and molecules using the power of plants, photosynthesis, and molecular biology. We aim to fundamentally transform agriculture and the food industry by decoupling the deleterious impact of animal agriculture from its byproducts and offering a more compelling, lower cost and sustainable means of production. Animal-identical benefits. Plant-grown production.
Biotechnology

2021

We are breaking down the barriers to safe and affordable universal stem cell therapies using our novel, broadly applicable and scalable purification platform.
Biotechnology

2024

We are on a mission to cure as many people as possible from disease - making the world stronger, together. We do this by empowering drug formulators to design new vaccines and therapeutics faster and make them more efficient by programming the quality and quantity of immunological responses. At iuvantium, we harness the power of cross disciplinary collaboration, cutting-edge technology, and ethical principles to revolutionize the field of immunotherapy. We strive to create a world where everyone, regardless of their background or circumstances, has access to the best healthcare. By merging immunology, AI, engineering principles, and materials science, we develop a scalable and cost-effective immune modulation platform. Our platform empowers immunotherapy developers to enhance the effectiveness of a vaccine/drug’s performance in real life settings and improve accessibility of their formulations, leading to breakthrough treatments for cancer and infectious diseases. We envision a future where the power of human compassion and collaboration transcends boundaries, making transformative healthcare solutions available to all. We aspire to be at the forefront of innovation in the field of immune therapies, revolutionizing the way diseases are treated and prevented. By decoding the intricacies of the immune system and harnessing the potential of inorganic materials, we pioneer novel approaches that shape the development of next-generation vaccines, cellular therapies, and drugs. Our vision is to serve as the catalyst for positive change, partnering with pharmaceutical companies to realize a world free from the shackles of cancer and infectious diseases. Through our work, we envision a future where preventable suffering is eradicated, lives are saved, and individuals are empowered to reach their fullest potential. Together, we will build a world where healthcare knows no boundaries and the human spirit.
Biotechnology

2023

Kerato Limited is pioneering the use of advanced tissue engineering technologies to develop biosynthetic, biosimilar corneas that have the potential to revolutionize corneal care for medical, research and commercial applications.
Biotechnology

2023

Since inception in 2002, Future Health Biobank has remained the largest and most pioneering UK stem cell bank, continuously setting standards for others to follow. We were the first private family bank in the UK to specialise in the processing, testing and long term storage of cord blood and cord tissue and since then, we have been entrusted with over 140,000 samples from more than 75,000 families from 75 countries. We have been certified and licensed by more regulators than any other stem cell bank. With two laboratories over two geographically separate locations and since incorporation we have been awarded a full HTA license, Swissmedic license, MHRA accreditation, AABB accreditation, and ISO 9001 certification. We are also the only UK family bank to have ever received the prestigious Queen’s Award for Enterprise.
Biotechnology

2002

Applied Photophysics, of Leatherhead, Surrey, UK, is a leading provider of solutions for the biophysical characterization of biomolecules and has been providing spectroscopy to the research community for over 50 years. Chirascan™ systems use the phenomenon of circular dichroism (CD) to characterize changes in the higher order structure of proteins. These systems are used in cutting-edge research and to support the development of innovator drugs and biosimilars in the biopharmaceutical industry. The company’s SX-range of stopped-flow spectrometers is acknowledged globally as the gold standard for kinetic studies of fast biochemical reactions. Through a joint venture with Fluorescence Innovations Inc of Minneapolis, MN, USA, operating as Protein Stable, we have also introduced easy-to-use high-throughput protein stability screening with microplate-based intrinsic fluorescence thermal ramping and chemical melt plate readers.
Biotechnology

1971

2BScientific is a leading distributor of innovative life science products, serving customers in the UK, Europe, and worldwide. Our top priority is always the customer, and we go above and beyond to provide exceptional service and innovative products that support scientific discovery. From cutting-edge assays and technologies to reagents for basic research, we offer a wide range of innovative products that are designed to meet the needs of researchers across a variety of disciplines.
Biotechnology

2009

Antibodies.com supplies high-quality antibodies, proteins, and ELISA kits to life science researchers at cost-effective prices. Headquartered in Cambridge (UK), and with offices in Stockholm (SE) and St Louis (MO, USA), we support life scientists worldwide by supplying the same high-quality products as the industry leading suppliers, that are sourced from the same primary manufacturers, but at more affordable prices. We can support your research with high-quality and characterized research tools, expert customer service, detailed product datasheets, and fast global delivery. Our growing product range caters for every discipline and includes: primary antibodies, secondary antibodies, ELISA kits, cell based assays, proteins and peptides, and other companion products. Discover more, for less.
Biotechnology

2015

SLS first began trading in 1991 and, since then, we have grown to become the UK’s largest independent supplier of laboratory equipment, chemicals and consumables. Because of our independence, we are unique in our approach to sourcing and supplying the highest quality, best value products and brands. We provide precisely what you need, when you need it, whether you’re searching for something specific or aiming to equip an entire laboratory. Whatever you are looking for, you can be sure our team will take care of you and provide a dedicated service that’s designed entirely around you and your business. From pipettes and petri dishes to the latest in laboratory instrumentation, we pride ourselves on the quality of products and the service we provide. In addition to manufacturing our own SLS Select consumable and chemical ranges, we partner with industry leading names including Sigma-Aldrich, Becton Dickinson, Eppendorf, Cytiva, DWK Life Sciences, Kimberly-Clark, Sartorius, Taylor Wharton, Thermo-Scientific, 3M and Corning. However specific your needs, you can be sure we’ll deliver precisely the quality you need.
Biotechnology

1991

Tx Five - Biotech's Best Friend. We pride ourselves on supporting your journey from the company you are today to the company you aspire to be. Specialising in comprehensive biotech expansions across Europe and the US, we take a holistic approach to assess and enhance clinical and pre-clinical departments from the CxO level downwards, ensuring you stay ahead of your competitors. Our proven track record includes partnering with leading biotechs pioneering innovations such as ADCs, CAR-T therapies, small molecules, checkpoint inhibitors, cancer vaccines, and other groundbreaking drug types across critical therapeutic areas. Beyond our operational focus, we are dedicated to giving back. 5% of our fees are donated to charities aligned with our clients' missions, making a meaningful impact on patient communities. Partnering with us allows you to make a difference in biotech and beyond. Areas we excel in: - Oncology & Haematology - Neurosciences - Rare Diseases - Immunology - Cell & Gene Therapy Businesses we assist: - Small to mid-sized biotechs with ongoing studies from pre-clinical to Phase IV Communities we donate to: - Charities dear to our clients' hearts
Biotechnology

2023

As the UK’s leading open-access genomics service provider, Edinburgh Genomics is firmly established as the partner of choice for all your sequencing and bioinformatics needs. We produce high-quality, high volume data for a global community of research collaborators and customers across academia, government and industry. Embedded within the rich academic environment of the University of Edinburgh and drawing on world class expertise, we have a proven track record of delivering quality results to exacting standards. The Edinburgh Genomics teams have been delivering genomics data and analysis to researchers for nearly 20 years. Work enabled by Edinburgh Genomics has supported more than 1,300 peer-reviewed publications.
Biotechnology

2013

Cellmark pioneered the introduction of DNA analysis for paternity testing. We deliver a next day service using the most conclusive 24 marker genetic test - across our range of DNA relationship testing services - that includes DNA testing for - Maternity, Sibling, Avuncular, Grandparentage and Immigration matters as well. If your samples reach us by 10am we can get the test report to you by the end of the next working day!
Biotechnology

1987

Epistem Ltd. is a leading contract service provider offering innovative preclinical research services, genetic and protein biomarker testing as well as histology services to pharmaceutical, biotech and academic customers to support to drug discovery and development pipelines. We have worked with over 200 pharmaceutical and biotechnology companies at both preclinical and clinical stages. Our high level of expertise and customer focus has led to an enviable track record and impressive amount of repeat business. Our preclinical contract research services group advance drug development programs for oncology, inflammatory, dermatology, auto-immune and GI disease indications. We offer an impressive range of preclinical models in these therapeutic areas. We also provide information relating to toxicity assessments and are experts in GI tox. We also offer a broad range of cell based assays including novel stem cell assays. Our biomarker services division offers GCLP compliant genetic testing, histology, FACS analysis and protein biomarker detection. Epistem’s genetics group offer gene expression and DNA genotyping sample analysis by NGS, microarray and qPCR. We specialise in working with small starting materials (down to a single cell input) applying our proprietary low input techniques and products to support drug development programs. We are specialists in fractionating cell populations and conducting genetic analysis. We have pioneered techniques using plucked scalp hair and laser capture microdissected material to provide gene expression biomarker information to drug development programs. Epistem is committed to provide reliable and innovative services to support all phases of drug development from to preclinical projects to clinical trials. Website: www.epsitem.co.uk
Biotechnology

2000

DNA Legal offer drug, alcohol, paternity, and forensic testing. We go to incredible lengths to help you find the truth, with hair strand testing for drugs and alcohol, legal paternity testing, relationship testing for immigration, forensic toxicology, and more. Our laboratories invest heavily in research, ensuring industry leading levels of sensitivity and accuracy. Because of this, DNA Legal offers the most detailed and wide ranging selection of testing available. But we won't stop at issuing your results - we assess and clearly explain the factors which underpin them. With a team that truly cares, we promise to support you at every step, from client care to expert witness testimony.
Biotechnology

2004

We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists'​ ability to use synthetic biology on a scale not currently possible.
Biotechnology

2015

Mission: Deliver low-cost, non-invasive in vitro diagnostics (IVDs) for high-incidence diseases at the point-of-care. Approach: Using Raman Spectroscopy and Surface Enhanced Raman Spectroscopy (SERS) to achieve detection beyond current standard-of-care IVDs. Existing research supports identifying target diseases in urine using this approach. Focus: Serox has attracted a fantastic array of scientific and medical advisors and has established clinical relationships to help validate its approach, initially in bladder, prostate and kidney cancers. The intention is to ‘bundle’ tests which may be requested together, say when a patient presents with blood in their urine. Women’s cancers will follow, along with point-of-care speciation of Urinary Tract Infections. Differentiation: Serox displaces chemistry with photonics and Machine Learning, to allow urinalysis to avoid invasive procedures (blood taking, biopsy cystoscopy). Serox is following a data-focussed path that will lead to the personalisation of IVD. Timeliness: Raman Spectroscopy and SERS have long been used in advanced laboratories. The price of lasers and detectors is falling, and the usability and deployability of Raman Spectrometer improving. Machine Learning allows the ability to diagnose from the aggregate of Raman shifts in complex liquids. Together this unlocks the use of Raman Spectroscopy as a routine diagnostic. Outcome: Serox offers the prospect of a low-cost cartridge that be used remotely to acquire a urine sample, or in a clinic at the point-of-care, that can be processed using a desktop analyser in less than three minutes to provide an answer with a high Negative Predictive Value, and sensitivity / specificity in line with the current standard-of-care. This could reduce referrals to cystoscopy and biopsy, ultimately transform screening, and reduce the unnecessary use of broad-spectrum antimicrobials.
Biotechnology

2018

Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions. By optimizing every component of our product candidates, we are improving genetic expression and targeted delivery to realize outsized clinical results. Building on the successes of our two potential first-in-class therapies for Gaucher disease and adrenomyeloneuropathy (AMN), we’re moving from rare diseases toward more widespread conditions, including forms of Parkinson’s and dementia, and even certain cardiovascular diseases. Expanding our impact, and pushing forward to new frontiers of genetic medicine. Toward life-changing therapies, and brighter futures. Toward More™
Biotechnology

2015

By mining the genome using our bioinformatics platform we discover and re-purpose natural gene regulatory elements, creating customised gene expression systems to: 1. Improve human health: Creating highly selective and controllable promoters and gene expression cassettes for novel gene and cell therapy systems. Improving the efficiency of biologics production by increasing protein yields in upstream manufacturing processes. 2. Engineer biology: Harnessing synthetic biology to make promoters for a wide array of chassis organisms used in Industrial Biotech. Creating switches and gene circuits that can be employed in the metabolic engineering applications. 3. Enable traits discovery: Designing tissue-selective plant synthetic promoters active across different crop species for Agricultural Biotech applications. Using plant genomics to facilitate the design of environmentally-regulated and pathogen-responsive promoters.
Biotechnology

2022

STORM Therapeutics is a biotechnology company creating novel therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. There are more than 150 RNA modifications reported and approximately 300 RNA modifying enzymes which represent novel therapeutic targets. STORM has leveraged its first mover advantage to establish a novel drug discovery and RNA analytics platform leading to the identification of novel targets and a proprietary pipeline of first in class small-molecule drug candidates for potential use in oncology, inflammation, viral infections, and CNS diseases. The pipeline is exemplified by STORM’s METTL3 inhibitor (STC-15) for which an IND has been filed with the FDA to support initiation of a Phase I clinical trial in cancer patients in 2022. STC-15 represents the first RNA modifying enzyme inhibitor to enter clinical evaluation in humans. Additional candidates are planned for advancement into IND-track activities in 2023. STORM has built an experienced R&D team who occupy modern, well-equipped laboratories on the Babraham Research Campus near Cambridge, UK. The company’s proprietary in house research is complemented by outsourcing of some discovery activities to high quality CRO partners (e.g., Evotec) enabling STORM to operate a cost efficient and flexible model.
Biotechnology

2015

Sterilab Services is a specialist diagnostic company dedicated to providing high quality solutions for healthcare professionals. Our products are widely used in the UK-in NHS and private sector hospitals, clinical laboratories, physician’s offices and other healthcare facilities. They can be found in both centralized laboratories and at the point of care. We work with leading international diagnostic companies in four main business areas: urinalysis, infectious disease, sample collection and transport and storage. Sterilab Services is a specialist diagnostic company dedicated to providing high quality solutions for healthcare professionals. Our products are widely used in the UK-in NHS and private sector hospitals, clinical laboratories, physician’s offices and other healthcare facilities. They can be found in both centralized laboratories and at the point of care. We work with leading international diagnostic companies in four main business areas: urinalysis, infectious disease, sample collection and transport and storage. Sterilab is committed to offer products of leading quality and design - which consistently meet or exceed the needs and expectations of the professionals we serve. We have a strong focus on continuous improvement and maintain an integrated Quality and service Management System (QMS) to deliver on this commitment Sterilab is committed to offer products of leading quality and design - which consistently meet or exceed the needs and expectations of the professionals we serve. This commitment is achieved through listening to our customers, bringing together proven manufacturers and systems to translate customer needs into innovative and reliable diagnostic solutions. We have a strong focus on continuous improvement and maintain an integrated Quality and service Management System (QMS) to deliver on this commitment
Biotechnology

2000

BioMedha is a UK-based pre-clinical CRO providing in vitro biology expertise to the global drug discovery industry. We are industry-experienced, in vitro biology-focused scientists and can add significant value to our client programmes by undertaking key elements of the early stage drug discovery process. BioMedha expertise includes: • HTA authorized establishment with on-site blood donor panel • Immunology, Oncology, Immuno-oncology, and inflammation studies • Target validation, assay development, screening, and MOA studies • Whole blood and Immune cell functional assays • Flow cytometry capabilities • Cytokine assays and Luminex multiplexing • Cell imaging expertise • Expression studies (protein levels, mRNA levels, and surface expression) • Plate reader-based assays (Fluorescence, Luminesce, Absorbance, FP, FRET, BRET, Alphascreen, HTRF) • Functional assays (e.g. signalling pathways, bioassays) • GPCRs: assay development and screening • Protein-Protein Interactions (PPI) • Enzyme activity • Discovery Toxicology studies We are a small but passionate team of scientists with substantial experience in the pharmaceutical and biotech industries, focused heavily on pre-clinical drug discovery biology. We serve clients in pharma, biotech, virtual companies, spin-outs, and academic institutions.
Biotechnology

2015

Haier Biomedical provides innovative, robust and sustainable products and services to the life science sector. We help organisations with their challenges by offering market-led, low-impact, quality and technologically-advanced products, which are trusted by scientists globally. As the local hub for Haier Biomedical our approach is to build partnerships with our clients, providing a personal touch, going the extra-mile and delivering value.
Biotechnology

2016

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of a functional cure for chronic HBV infection; VTP-1000, an autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease; and VTP-850, a second-generation immunotherapeutic candidate designed to treat recurrent prostate cancer. Barinthus Biotherapeutics’ proven scientific expertise, diverse portfolio and focus on pipeline development uniquely positions the company to navigate towards delivering treatments for people with infectious diseases, autoimmunity and cancers that have a significant impact on their everyday lives.
Biotechnology

2016

Founded in 2004 and headquartered in Warrington, Cheshire, AlphaBiolabs is a leading and award-winning provider of DNA, drug, alcohol, and health testing services across the UK. We employ state-of-the-art techniques to provide timely, accurate, and cost-efficient testing to meet a range of needs. Our client base includes businesses of all sizes across every sector, family and immigration law solicitors, social services, local authorities, members of the public, and the media. Our laboratory is accredited to the international quality standards UKAS ISO 17025 and ISO 9001, and our test results are accepted by the Ministry of Justice, the Home Office, UK Visas and Immigration, HM Passport Office, Border Force, and Immigration Enforcement. We also operate a network of walk-in centres in 21 locations across the UK and Ireland.
Biotechnology

2004

Astell Scientific has been a world leading manufacturer and supplier of laboratory, pharmaceutical & hospital autoclaves and sterilizers for over a century, shipping thousands of autoclaves around the world. Through continuing investment in product development and information technology, Astell Scientific offers high quality products manufactured in the UK and backed up by efficient order processing and prompt dispatch. During the last twenty years Astell Scientific have developed a reputation as specialist manufacturers of sterilization equipment, producing a wide range of front and top-loading PLC controlled Autoclaves and Sterilizers designed to meet the exacting demands of the modern Laboratory, Pharmaceutical and Medical professionals. All Astell Scientific autoclaves, Steam Generators and Effluent Decontamination systems (EDS) incorporate the latest innovations in control system technology, providing colour touchscreen controllers, on screen tutorial, 5 password levels, multiple cycle programming, secure data archiving, and delayed start facility all included as standard throughout the range. These include: Circular section units from 30-330 litres Square Section units from 125 - 2000 litres Steam Generators up to 72 kW Effluent Decontamination Systems (EDS) designed to your needs Other items we produce: Nelldorn Glassware Dryers Hearson Tobacco Ovens #autoclave #sterilizer #sterilisation
Biotechnology

1884

Talent Consultancy -Understanding people, using our approach, enables you to determine how well your staff are engaged, help them to think through their career and put in place succession and people expansion plans. Coaching - I provide you with an opportunity to evaluate your unique contribution in the workplace, work effectively in teams and explore how to make the most of your career. Team Coaching -We use group online sessions to build respect and trust within and between small teams. Everyone is brilliant; we just need to understand how these skills can best be utilised. Senior Recruitment -We can deliver senior level executive search assignments built on a strong understanding of your organisation. This is done with our recruitment partner - Horton International.
Biotechnology

2015

Secure, transparent compression for genomic data. PetaGene helps organisations manage their rapidly growing genomic data using transparent lossless compression and encryption. PetaGene's multi award-winning software significantly reduces storage and access costs, accelerates transfers and analyses, and simplifies cloud integration for genomic data. It also helps manage compliance through encryption and deep auditing. Large pharma, commercial, clinical and academic labs use PetaGene to cut costs, reduce turn-around times, and add new capabilities to their genomic workflows without disruption to their users or technology framework. For more information, please visit: https://www.petagene.com
Biotechnology

2016

Stemnovate provides innovative technologies for drug screening and safety testing. We have developed state of the art platform technologies, underpinned by experience in tissue procurement, cell biology, high through put imaging and microfluidics. We provide a customer friendly and flexible platform for human drug discovery which overcome many of the limitations associated with mammalian cell lines and in vivo models.
Biotechnology

2016

Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs.
Biotechnology

2012

List of Biotechnology companies in United Kingdom (UK)

Company Name

Location

Category

Employees

Website

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

https://sanogenetics.com/

Bristol, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://sciencecreates.co.uk/

Oxford, United Kingdom (UK)

Science and Engineering
Science and Engineering

30-50

https://www.theolytics.com/

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

https://biomodal.com/

Glasgow, United Kingdom (UK)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.causewaytherapeutics.com/

Edinburgh, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://emimaging.com/

London, United Kingdom (UK)

Health and Medical
+1
Health and Medical, Science and Engineering

30-50

https://hertilityhealth.com/

Altrincham, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://utilitytherapeutics.com/

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.basecamp-research.com

Manchester, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://www.brightbiotech.co.uk

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

https://lifebit.ai

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

http://www.mogrify.co.uk

Edinburgh, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

https://www.roslintech.com

Edinburgh, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

https://www.rhizocore.com/

Chorley, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://www.richmondscientific.com

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

http://www.synthace.com

Stratford-upon-avon, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://www.pathologynews.com

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://cellomaticsbio.com/

High Peak, United Kingdom (UK)

Science and Engineering
Science and Engineering

200-500

http://www.conceptlifesciences.com

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

https://multus.bio

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://eden.bio/

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://www.kyomei.co.uk

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://plurify.bio

Oxfordshire, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://iuvantium.com

Newcastle Upon Tyne, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://kerato.co.uk

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

http://www.futurehealthbiobank.com

Leatherhead, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

https://www.photophysics.com/

Kirtlington, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.2bscientific.com

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://www.antibodies.com

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

https://www.scientificlabs.co.uk

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://www.txfive.com/

Edinburgh, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://genomics.ed.ac.uk

Abingdon, United Kingdom (UK)

Science and Engineering
Science and Engineering

200-500

https://www.cellmark.co.uk/

Manchester, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.epistem.co.uk

Frome, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.dnalegal.com

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

http://www.evonetix.com

Long Hanborough, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://www.serox.ai

Stevenage, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

http://www.spurtherapeutics.com

Edinburgh, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

http://www.chromatinbio.com

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.stormtherapeutics.com

Wetherby, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://www.sterilab.co.uk/

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://biomedha.com

Sunbury on Thames, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.haierbiomedical.co.uk/

Harwell, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

https://www.barinthusbio.com

Warrington, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

http://www.alphabiolabs.co.uk

Sidcup, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

https://www.astell.com

Bristol, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

http://www.biosocius.com

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://www.petagene.com/

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

http://www.stemnovate.co.uk

Sandwich, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

http://www.discovery-park.co.uk/

100/191 results

Frequently asked questions

Updated 23 October 2026

What is Enterprise League?

Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.

Is it free to list my company?

Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.

How does verification work, and what does it cost?

Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.

Where does the company information come from?

Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.

How do I claim or correct my company’s profile?

Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.